RGNCY-0001 (GS9620, TLR7 agonist)
GS-9620 is a potent (3nM) and selective Pteridinone based agonist of
TLR7 suitable for oral dosing. GS-9620 is currently undergoing clinical
evaluation for the treatment of chronic HBV infection.
SMILES: NC1=C2C(N(CC3=CC=CC(CN4CCCC4)=C3)CC(N2)=O)=NC(OCCCC)=N1
Systematic Name: 4-amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5H)-one
Formula: C22H30N6O2
Molecular
Weight: 410.51
PMID: 23961878
Reference: Roethle, Paul A., et al. "Identification and optimization of pteridinone toll-like receptor 7 (TLR7) agonists for the oral treatment of viral hepatitis." Journal of Medicinal Chemistry 56.18 (2013): 7324-7333.
Interested in this reagent? E-mail us at info@reagency.co and let us know.
